To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that happens, newly-funded health technologies won’t get to those most in need.
Articles on Insulin pump
Displaying all articles
People with diabetes are about twice as likely to become seriously ill with COVID-19 compared with those who don’t have diabetes.
From breast implants to prosthetic knees, implants can trigger a foreign body response that results in your body rejecting them. Suppressing an immune cell gene could reduce this risk.
On the centenary of insulin’s first use, doctors, researchers and people with diabetes are asking why New Zealand lags other countries in funding the latest devices to monitor blood sugar.
Small-batch brewers are starting to tinker with biologic drugs to meet their own medical needs. A side effect of their success would be a disruption to how big pharma makes and distributes drugs.
A sufficiently talented brainjacker could one day influence the behaviour of a person in worrying ways.
Top contributors
-
PhD candidate, University of Oxford
-
Professor, Abell Chair in Synthetic Biology, Colorado State University
-
Postdoctoral Researcher in Chemical and Biological Engineering, Colorado State University
-
Research Manager, Edgar Diabetes and Obesity Research Centre; Science Communicator, Healthier Lives–He Oranga Hauora National Science Challenge, University of Otago
-
Assistant Professor of Surgery, University of Arizona
-
Associate Professor of Paediatric Endocrinology, University of Otago
-
Professor of Medicine and Director, Healthier Lives–He Oranga Hauora National Science Challenge and Co-Director, Edgar Diabetes and Obesity Research Centre, University of Otago
-
Assistant Professor of Health Promotion and Policy, UMass Amherst
-
Associate Professor, Paediatrics, University of Otago
-
Associate Professor, Health Sciences, University of Waikato
-
Senior Lecturer, School of Health, University of Waikato